Priority setting in health: origins, description and application of the Australian Assessing Cost-Effectiveness initiative
Carter, Rob, Vos, Theo, Moodie, Marj, Haby, Michelle, Magnus, Anne and Mihalopoulos, Cathrine 2008, Priority setting in health: origins, description and application of the Australian Assessing Cost-Effectiveness initiative, Expert review of pharmacoeconomics & outcomes research : informing decision-making in the delivery of cost-effective healthcare, vol. 8, no. 6, pp. 593-617.
Attached Files
(Some files may be inaccessible until you login with your Deakin Research Online credentials)
Expert review of pharmacoeconomics & outcomes research : informing decision-making in the delivery of cost-effective healthcare
Volume number
8
Issue number
6
Start page
593
End page
617
Publisher
Expert Reviews Ltd
Place of publication
London, England
Publication date
2008-12
ISSN
1473-7167 1744-8379
Summary
This article reports on the ‘Assessing Cost–Effectiveness’ (ACE) initiative in priority setting from Australia. It commences with why priority setting is topical and notes that a wide variety of approaches are available. In assessing these various approaches, it is argued that a useful first step is to consider what constitutes an ‘ideal’ approach to priority setting. A checklist to guide priority setting is presented based on guidance from economic theory, ethics and social justice, lessons from empirical experience and the needs of decision-makers. The checklist is seen as an important contribution because it is the first time that criteria from such a broad range of considerations have been brought together to develop a framework for priority setting that endeavors to be both realistic and theoretically sound. The checklist will then be applied to a selection of existing approaches in order to illustrate their
deficiencies and to provide the platform for explaining the unique features of the ACE approach. A case study (ACE-Cancer) will then be presented and assessed against the checklist, including reaction from stakeholders in the cancer field. The article concludes with an overview of the full body of ACE research completed to date, together with some reflections on the ACE experience.
Notes
Reproduced with the kind permission of the copyright owner.
Unless expressly stated otherwise, the copyright for items in Deakin Research Online is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.